Navigation Links
Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs
Date:11/9/2009

ANN ARBOR, Mich., Nov. 9 /PRNewswire/ -- Thomson Reuters today announced the newest release of Clinical Xpert(TM) CareFocus, a leading clinical surveillance solution that enables hospitals to identify at-risk patients in real-time and respond immediately to improve clinical quality and reduce total cost of treatment.

This upgrade is available to current CareFocus customers at no additional cost.

CareFocus 2.0 contains several powerful enhancements that improve clinical quality and efficiency. New features include forms capture, e-mail and text notifications, additional searchable data elements and pre-configured profiles that target Patient Safety Indicators and Never Events (those events that never should occur such as serious disability associated with a medication error).

Forms Capture: With this feature, hospital clinicians can track and document their interventions with patients at the point-of-care via a mobile device or Web portal. Centralized, electronic forms allow multiple clinicians to see the same patient information -- anytime, anywhere. For example, a nurse care manager, infection control specialist, or pharmacist can view a patient's forms instantly when they appear on the clinician's auto-generated CareFocus patient list.

Improved Alerts: CareFocus 2.0 offers improved alerting capability that notifies clinicians of high-risk patients via email or text message, letting all relevant clinicians know about critical at-risk patients the moment they are identified.

Improved Access to Information: This latest release also includes the ability to query on additional data elements from the Medication Administration Record, working diagnosis, and active orders display.

Improved Reporting: The new functionality allows hospitals administrators to run customized summary reports for each forms category, making it easy to report on clinical activity and associated costs.

"Whether associating cost savings for an intravenous-to-oral medication conversion in the pharmacy or estimating the cost of successfully preventing an adverse event such as sepsis, users can quantify the impact of their work," said Jill Sutton, vice president of product management for the Healthcare & Science business of Thomson Reuters. "And hospitals can measure a tangible return on their IT investment."

CareFocus is part of the Clinical Xpert suite of workflow solutions (formerly MercuryMD MData) that has been recognized as a KLAS Category Leader for Mobile Data Systems for seven consecutive years. The Clinical Xpert suite includes the market-leading CareFocus clinical surveillance solution as well as offerings that provide easy access to critical patient information at the point of care, charge and procedure management, care team coordination, and medication reconciliation.

"With these new features, CareFocus will continue to help hospitals lower mortality, prevent Never Events, and reduce treatment costs," Sutton said.

To learn more about CareFocus, visit here. (http://thomsonreuters.com/products_services/healthcare/healthcare_products/clinical_deci_support/clinical_xpert_clinical_wfs/clinical_xpert_carefocus?parentKey=486686)

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto Stock Exchange (TSX: TRI) and New York Stock Exchange (NYSE: TRI). For more information, go to www.thomsonreuters.com.

SOURCE Thomson Reuters


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety
2. General Practitioners Write Most Prescriptions for Mental Health Drugs, According to Study from Thomson Reuters and SAMHSA
3. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
4. Thomson Healthcare Cancer Profiler Used in Study
5. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
8. Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
9. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
10. Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
11. BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):